Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

Periconceptional folate supplementation reduces the risk of neural-tube defects. We studied the frequency of the 677C-->T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in 55 patients with spina bifida and parents of such patients (70 mothers, 60 fathers). 5% of 207 controls were homozygous for the 677C-->T mutation compared with 16% of mothers, 10% of fathers, and 13% of patients. The mutation was associated with decreased MTHFR activity, low plasma folate, and high plasma homocysteine and red-cell folate concentrations. The 677C-->T mutation should be regarded as a genetic risk factor for spina bifida.

[1]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[2]  H. Blom,et al.  Three Different Methods for the Determination of Total Homocysteine in Plasma , 1995, Annals of clinical biochemistry.

[3]  A. Czeizel,et al.  Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation , 1992 .

[4]  M. Norusis,et al.  Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. , 1991, American journal of human genetics.

[5]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[6]  H. Blom,et al.  Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? , 1994, Metabolism: clinical and experimental.

[7]  R. Matthews,et al.  Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification , 1994, Nature Genetics.

[8]  H. Blom,et al.  Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. , 1995, American journal of human genetics.

[9]  J. Mills,et al.  Homocysteine metabolism in pregnancies complicated by neural-tube defects , 1995, The Lancet.

[10]  Prevention of neural tube defects: Results of the Medical Research Council vitamin study , 1991 .

[11]  H. Blom,et al.  Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? , 1995, The Lancet.